Events

Brokerage and networking event for cluster 6 calls
APR
Tue
29
APR
Wed
30

This was 6 months ago

Location

Brussels

April 29, Comet Meetings, Place Stéphanie 20, 1050 Brussels.
April 30 NCBR Office, Rue Belliard 40, 1040 Brussels.
Programmes
Agro-Food, Environment

The calls in cluster 6 of Horizon Europe will soon be published. Some consortia are still looking for extra partners and a brokerage event is the ideal venue to find them. There is already a bigger event planned in Warsaw at the end of May but our central European partners have also decided to organise one on the 29th and 30th of April in Brussels. The full title of the event is "transforming our future: sustainability and beyond- for a greener planet" and these are the organisers:

  • four Hungarian Universities: Eötvös Loránd University (ELTE), and Corvinus University of Budapest, University of Pannonia, Hungarian University of Agriculture and Life Sciences (MATE),
  • the Lithuanian RDI Liaison Office in Brussels (LINO),
  • the NCBR Office in Brussels (Business & Science Poland)

This is an ideal opportunity if you are missing a partner from central Europe or the baltics in your consortium. The full programme and registration details can be found here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.